UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
Simulating Ancestrally Unbiased Tumor Evolution To Interrogate Drug Resistance
Simulating Ancestrally Unbiased Tumor Evolution To Interrogate Drug Resistance is a funding opportunity from UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, up to 1453500, closing August 31, 2026.
Aug 31, 2026
(31d left)Overview
PROJECT SUMMARY Among cancer patients of distinct ancestries, there are molecular differences in the composition of their tumors, and their responses to therapies. These molecular distinctions extend well beyond germline differences, and encompass somatic and non-mutational alterations as well. Compared to…